HYPAQUE SODIUM 20% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hypaque Sodium 20%, and when can generic versions of Hypaque Sodium 20% launch?
Hypaque Sodium 20% is a drug marketed by Ge Healthcare and is included in one NDA.
The generic ingredient in HYPAQUE SODIUM 20% is diatrizoate sodium. There are eleven drug master file entries for this compound. Additional details are available on the diatrizoate sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYPAQUE SODIUM 20%?
- What are the global sales for HYPAQUE SODIUM 20%?
- What is Average Wholesale Price for HYPAQUE SODIUM 20%?
Summary for HYPAQUE SODIUM 20%
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 35 |
| Clinical Trials: | 1 |
| DailyMed Link: | HYPAQUE SODIUM 20% at DailyMed |
Recent Clinical Trials for HYPAQUE SODIUM 20%
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Institute of Liver and Biliary Sciences, India | N/A |
US Patents and Regulatory Information for HYPAQUE SODIUM 20%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ge Healthcare | HYPAQUE SODIUM 20% | diatrizoate sodium | SOLUTION;URETERAL | 009561-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
